AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33314364 — intervention group
Group type: COMPARATOR
Intervention: Univariate methods with multiple imputation
Number of subjects: 0
Study 35535503 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine (100 µg)
Number of subjects: 1457
Study 35535503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1457
Study 33567961 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive tasks (difficult vs easy)
Number of subjects: 80
Study 33567961 — intervention group
Group type: EXPERIMENTAL
Intervention: Catastrophizing
Number of subjects: 80
Study 33567961 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 80
Study 33567961 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear-avoidance model variables
Number of subjects: 80
Study 35142904 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent mesh
Number of subjects: 255
Study 35142904 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable mesh
Number of subjects: 255
Study 35142904 — intervention group
Group type: COMPARATOR
Intervention: No mesh
Number of subjects: 255
Study 34784916 — intervention group
Group type: EXPERIMENTAL
Intervention: Dove Confident Me Indonesia: Single Session intervention delivered by trained teachers or school guidance counsellors
Number of subjects: 2000
Study 34784916 — intervention group
Group type: EXPERIMENTAL
Intervention: Dove Confident Me Indonesia: Single Session intervention
Number of subjects: 2000
Study 35074566 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal blood glucose (euglycemia)
Number of subjects: 26
Study 35074566 — intervention group
Group type: EXPERIMENTAL
Intervention: High blood glucose (hyperglycemia)
Number of subjects: 26
Study 34536595 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop on synthetic bone (group 1)
Number of subjects: 23
Study 34536595 — intervention group
Group type: COMPARATOR
Intervention: Theoretical instruction only (group 2)
Number of subjects: 23
Study 34536595 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents with previous experience in spinal surgery
Number of subjects: 23
Study 34536595 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents trained by simulation
Number of subjects: 23
Study 34387740 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-leucine (NALL) 4 g/day for patients ≥ 13 years, weight-tiered doses for patients 6-12 years
Number of subjects: 33
Study 34387740 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-leucine (NALL)
Number of subjects: 33
Study 34820034 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergoferon
Number of subjects: 282
Study 34820034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 35517892 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (21 mg/day)
Number of subjects: 60
Study 35517892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32297703 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarenal artery infusion of autologous peripheral-blood-derived CD34+ cells (2.5 × 10^7 cells for each intrarenal artery)
Number of subjects: 52
Study 32297703 — intervention group
Group type: COMPARATOR
Intervention: Standardized pharmacotherapy only (control group)
Number of subjects: 52
Study 32297703 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarenal artery infusion of autologous peripheral-blood-derived CD34+ cells
Number of subjects: 52
Study 36457297 — intervention group
Group type: EXPERIMENTAL
Intervention: Attempted Suicide Short Intervention Program (ASSIP)
Number of subjects: 239
Study 36457297 — intervention group
Group type: COMPARATOR
Intervention: Crisis Counseling (CC)
Number of subjects: 239
Study 33793585 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial teardrops for left eye and normal saline for right eye (Group A)
Number of subjects: 79
Study 33793585 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene covers for left eye and normal saline for right eye (Group B)
Number of subjects: 79
Study 33793585 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene covers for left eye and artificial teardrops for right eye (Group C)
Number of subjects: 79
Study 33793585 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene eye covers (all groups)
Number of subjects: 79
Study 35504735 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized digital photographs (ELAB)
Number of subjects: 162
Study 35504735 — intervention group
Group type: COMPARATOR
Intervention: VITA Easyshade spectrophotometer (ES) (control group)
Number of subjects: 162
Study 34559113 — intervention group
Group type: EXPERIMENTAL
Intervention: Chuna Manual Therapy (CMT) administered once a week for 8 weeks
Number of subjects: 40
Study 34559113 — intervention group
Group type: COMPARATOR
Intervention: Standard drug treatment (Control)
Number of subjects: 40
Study 35449560 — intervention group
Group type: EXPERIMENTAL
Intervention: CIMT plus active rTMS
Number of subjects: 40
Study 35449560 — intervention group
Group type: COMPARATOR
Intervention: CIMT plus sham rTMS
Number of subjects: 40
Study 32017768 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley genotypes infected with Fusarium culmorum spores before heading
Number of subjects: 100
Study 34963654 — intervention group
Group type: EXPERIMENTAL
Intervention: Media exposure
Number of subjects: 613
Study 34963654 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressful life events (SLE)
Number of subjects: 613
Study 34963654 — intervention group
Group type: EXPERIMENTAL
Intervention: Harsh parenting
Number of subjects: 613
Study 34963654 — intervention group
Group type: EXPERIMENTAL
Intervention: Child age and white non-Hispanic race
Number of subjects: 613
Study 34963654 — intervention group
Group type: COMPARATOR
Intervention: Latent growth modeling (LGM) without covariates
Number of subjects: 613
Study 34963654 — intervention group
Group type: COMPARATOR
Intervention: Latent growth modeling (LGM) with covariates
Number of subjects: 613
Study 35149988 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong Families, Strong Communities (SFSC) program
Number of subjects: 1249
Study 35149988 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 1249
Study 34968730 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg QD
Number of subjects: 107
Study 34968730 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg QD
Number of subjects: 107
Study 34968730 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-escalated group (upadacitinib 30 mg QD)
Number of subjects: 107
Study 33865330 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ppm iNO
Number of subjects: 10
Study 33865330 — intervention group
Group type: COMPARATOR
Intervention: 0 ppm iNO
Number of subjects: 10
Study 33865330 — intervention group
Group type: EXPERIMENTAL
Intervention: iCPR
Number of subjects: 10
Study 32688046 — intervention group
Group type: EXPERIMENTAL
Intervention: STARC (Skills‐Training of Affect Regulation–A Culture‐sensitive Approach)
Number of subjects: 44
Study 34192724 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management intervention
Number of subjects: 220
Study 34192724 — intervention group
Group type: COMPARATOR
Intervention: Routine HIV-related care (Control)
Number of subjects: 220
Study 34192724 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Case management and Control)
Number of subjects: 220
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: General population
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: Families of TB patients
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: TB patients
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: General population with education above secondary school
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: General population with high knowledge about TB
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: Families of TB patients with education above secondary school
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: TB patients with education above secondary school
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: TB patients in the first wealth quintile
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: TB patients in the third wealth quintile
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of job loss
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolation
Number of subjects: 3463
Study 32028914 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling avoided
Number of subjects: 3463
Study 37154505 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid catheter
Number of subjects: 50
Study 37154505 — intervention group
Group type: COMPARATOR
Intervention: Soft catheter
Number of subjects: 50
Study 34185829 — intervention group
Group type: EXPERIMENTAL
Intervention: DTE
Number of subjects: 75
Study 34185829 — intervention group
Group type: EXPERIMENTAL
Intervention: LT4 + LT3
Number of subjects: 75
Study 34185829 — intervention group
Group type: COMPARATOR
Intervention: LT4
Number of subjects: 75
Study 32032408 — intervention group
Group type: EXPERIMENTAL
Intervention: FGG+HA
Number of subjects: 40
Study 32032408 — intervention group
Group type: COMPARATOR
Intervention: FGG alone
Number of subjects: 40
Study 35738801 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune checkpoint inhibitors (ICIs) treatment for uHCC
Number of subjects: 20
Study 35738801 — intervention group
Group type: COMPARATOR
Intervention: Preferable microbial signature in validation cohort
Number of subjects: 20
Study 33751620 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginal modeling approaches for the analysis of CRTs with truncated counts.
Number of subjects: 0
Study 33751620 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size formulas for CRTs with truncated counts.
Number of subjects: 0
Study 33751620 — intervention group
Group type: EXPERIMENTAL
Intervention: Power calculation for a malaria control CRT.
Number of subjects: 0
Study 32314621 — intervention group
Group type: EXPERIMENTAL
Intervention: Locking Plates (LPs)
Number of subjects: 64
Study 32314621 — intervention group
Group type: COMPARATOR
Intervention: Hook Plates (HPs)
Number of subjects: 64
Study 33111587 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone (KET)
Number of subjects: 32
Study 33111587 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 32
Study 33829647 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 371
Study 33829647 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin followed by a vitamin K antagonist
Number of subjects: 371
Study 36333174 — intervention group
Group type: EXPERIMENTAL
Intervention: Rater training
Number of subjects: 16
Study 33753442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention (exercise and dietary advice)
Number of subjects: 0
Study 33753442 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise only
Number of subjects: 0
Study 33753442 — intervention group
Group type: COMPARATOR
Intervention: No interventions (Control group)
Number of subjects: 0
Study 32028504 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor Agentry Scale (continuous and categorical variable)
Number of subjects: 5185
Study 32028504 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor Agentry Scale score
Number of subjects: 5185
Study 32028504 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor Agentry Scale scores in the lowest two quintiles
Number of subjects: 5185
Study 35380646 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of the California Gun Violence Restraining Order (GVRO) law in San Diego County from 2016 to 2019
Number of subjects: 355
Study 33247492 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory thyroidectomy
Number of subjects: 411
Study 36745167 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol
Number of subjects: 50
Study 36745167 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 50
Study 36745167 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol and Propofol
Number of subjects: 50
Study 33528648 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology lenses
Number of subjects: 36
Study 32168362 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants acting in trans
Number of subjects: 0
Study 32168362 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants acting in cis
Number of subjects: 0
Study 32168362 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian Randomization
Number of subjects: 0
Study 35380053 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate
Number of subjects: 268
Study 35380053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study 33773988 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent nonpharmacologic intervention aimed at improving sleep-wake disruption (nighttime and daytime interventions)
Number of subjects: 646
Study 33773988 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent nonpharmacologic intervention
Number of subjects: 646
Study 33773988 — intervention group
Group type: COMPARATOR
Intervention: Preintervention period (baseline)
Number of subjects: 646
Study 35962310 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibrated PRO instruments
Number of subjects: 0
Study 35962310 — intervention group
Group type: COMPARATOR
Intervention: Non-calibrated PRO instruments
Number of subjects: 0
Study 33789444 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotator cuff tear label
Number of subjects: 1308
Study 33789444 — intervention group
Group type: EXPERIMENTAL
Intervention: Subacromial impingement syndrome label
Number of subjects: 1308
Study 33789444 — intervention group
Group type: COMPARATOR
Intervention: Bursitis label
Number of subjects: 1308
Study 33104028 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-Component Cognitive Stimulation Therapy (SADEM)
Number of subjects: 67
Study 33104028 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study 35708700 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive hot water immersion (PHWI)
Number of subjects: 15
Study 35708700 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise (HIIE)
Number of subjects: 15
Study 35708700 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (continuous)
Number of subjects: 15
Study 32505810 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral xylitol wipes (7 g xylitol)
Number of subjects: 30
Study 32505810 — intervention group
Group type: COMPARATOR
Intervention: Standard oral hygiene regimen (SOC)
Number of subjects: 30
Study 36093602 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 513
Study 36093602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study 33653616 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 90
Study 33653616 — intervention group
Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 90
Study 32249915 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI (no testing)
Number of subjects: 538
Study 32249915 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI + 30min waiting phase
Number of subjects: 538
Study 32249915 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI + ATP
Number of subjects: 538
Study 32249915 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI + 30min + ATP
Number of subjects: 538
Study 32249915 — intervention group
Group type: COMPARATOR
Intervention: Patients with AF recurrence
Number of subjects: 538
Study 32249915 — intervention group
Group type: COMPARATOR
Intervention: Patients without AF recurrence
Number of subjects: 538
Study 36210436 — intervention group
Group type: EXPERIMENTAL
Intervention: ED GOAL intervention administered by trained nurses
Number of subjects: 120
Study 36210436 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 120
Study 34836170 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based diet index
Number of subjects: 710
Study 34836170 — intervention group
Group type: EXPERIMENTAL
Intervention: Nut intake
Number of subjects: 710
Study 34836170 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit intake
Number of subjects: 710
Study 34836170 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable intake
Number of subjects: 710
Study 35746524 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous vaccine treatment (M. bovis, M. bovoculi, Mycoplasma bovoculi antigens)
Number of subjects: 1198
Study 35746524 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial M. bovis vaccine treatment
Number of subjects: 1198
Study 35746524 — intervention group
Group type: COMPARATOR
Intervention: Sham vaccine treatment (adjuvant only)
Number of subjects: 1198
Study 35746524 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous vaccine treatment
Number of subjects: 1198
Study 35746524 — intervention group
Group type: COMPARATOR
Intervention: Sham vaccine treatment
Number of subjects: 1198
Study 35010908 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low-Calorie Ketogenic Diet (VLCKD, 600-800 kcal/day)
Number of subjects: 20
Study 35010908 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean Diet (MedDiet, estimated reduction of 500 kcal on the usual intake)
Number of subjects: 20
Study 34263623 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative low-dose ketamine (0.2 mg/kg/h)
Number of subjects: 32
Study 34263623 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion (control)
Number of subjects: 32
Study 33008485 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixator method
Number of subjects: 95
Study 33008485 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternation method
Number of subjects: 95
Study 33008485 — intervention group
Group type: COMPARATOR
Intervention: Adhesive/twill tape method
Number of subjects: 95
Study 36005394 — intervention group
Group type: EXPERIMENTAL
Intervention: Early tensile loading (loaded group)
Number of subjects: 40
Study 36005394 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 34422157 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1g in 10mls IV)
Number of subjects: 244
Study 34422157 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (10ml)
Number of subjects: 244
Study 32034908 — intervention group
Group type: EXPERIMENTAL
Intervention: Looming vulnerability guided imagery induction
Number of subjects: 278
Study 32034908 — intervention group
Group type: COMPARATOR
Intervention: Neutral guided imagery exercises (Control)
Number of subjects: 278
Study 35862873 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin (3.6 mg subcutaneously once every 28 days)
Number of subjects: 924
Study 35862873 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (40 mg orally once daily)
Number of subjects: 924
Study 35862873 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined goserelin and tamoxifen
Number of subjects: 924
Study 35862873 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 924
Study 35862873 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 924
Study 35862873 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen added to goserelin
Number of subjects: 924
Study 35862873 — intervention group
Group type: COMPARATOR
Intervention: Control (no adjuvant endocrine therapy)
Number of subjects: 924
Study 34822235 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual intervention (5 sessions before chemotherapy)
Number of subjects: 74
Study 34822235 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 74
Study 32744599 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual pelvic floor muscle training (PFMT)
Number of subjects: 362
Study 32744599 — intervention group
Group type: COMPARATOR
Intervention: Group-based pelvic floor muscle training (PFMT)
Number of subjects: 362
Study 32744599 — intervention group
Group type: COMPARATOR
Intervention: Individual PFMT and Group-based PFMT
Number of subjects: 362
Study 36446550 — intervention group
Group type: EXPERIMENTAL
Intervention: Double pigtail technique (DPT)
Number of subjects: 42
Study 36446550 — intervention group
Group type: COMPARATOR
Intervention: Lumen-apposing metal stents (LAMS)
Number of subjects: 42
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaware of physical activity monitoring (Phase I for group A)
Number of subjects: 35
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Aware of physical activity monitoring (Phase II for group A)
Number of subjects: 35
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaware of physical activity monitoring (Phase II for group B)
Number of subjects: 35
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Aware of physical activity monitoring (Phase I for group B)
Number of subjects: 35
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Total physical activity (assessed by IPAQ)
Number of subjects: 35
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity (assessed by IPAQ)
Number of subjects: 35
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy expenditure (assessed by IPAQ)
Number of subjects: 35
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behaviour (assessed by ActiGraph)
Number of subjects: 35
Study 34982448 — intervention group
Group type: EXPERIMENTAL
Intervention: Average number of steps (assessed by ActiGraph)
Number of subjects: 35
Study 32964833 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioids only
Number of subjects: 300
Study 32964833 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of opioids and non-opioid CNSAM
Number of subjects: 300
Study 32964833 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-opioid CNSAM only
Number of subjects: 300
Study 32964833 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no medication use)
Number of subjects: 300
Study 35460726 — intervention group
Group type: EXPERIMENTAL
Intervention: Vebicorvir (VBR) 300 mg once daily + NrtI
Number of subjects: 73